Khouri J - Search Results

1

Validation of the CIBMTR scoring system in predicting early relapse of multiple myeloma after autologous hematopoietic cell transplant.

Awada H, Hajj Ali A, Anwer F, Sauter C, Williams L, Khouri J. Awada H, et al. Among authors: khouri j. Bone Marrow Transplant. 2023 Sep;58(9):1057-1058. doi: 10.1038/s41409-023-02024-1. Epub 2023 Jun 23. Bone Marrow Transplant. 2023. PMID: 37353570 No abstract available.

2

Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients.

Chaulagain CP, Diacovo JM, Elson L, Comenzo RL, Samaras C, Anwer F, Khouri J, Landau H, Valent J. Chaulagain CP, et al. Among authors: khouri j. Clin Lymphoma Myeloma Leuk. 2020 Mar;20(3):e137-e143. doi: 10.1016/j.clml.2019.12.022. Epub 2020 Jan 8. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32029395 Free PMC article. No abstract available.

3

Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury.

Hu Y, Yang C, Amorim T, Maqbool M, Lin J, Li C, Fang C, Xue L, Kwart A, Fang H, Yin M, Janocha AJ, Tsuchimoto D, Nakabeppu Y, Jiang X, Mejia-Garcia A, Anwer F, Khouri J, Qi X, Zheng QY, Yu JS, Yan S, LaFramboise T, Anderson KC, Herlitz LC, Munshi NC, Lin J, Zhao J. Hu Y, et al. Among authors: khouri j. Cancer Res. 2021 Feb 1;81(3):713-723. doi: 10.1158/0008-5472.CAN-20-1010. Epub 2020 Dec 7. Cancer Res. 2021. PMID: 33288657 Free PMC article.

4

Outcomes and factors impacting use of axicabtagene ciloleucel in patients with relapsed or refractory large B-cell lymphoma: results from an intention-to-treat analysis.

Mian A, Wei W, Winter AM, Khouri J, Jagadeesh D, Anwer F, Gerds AT, Dean RM, Sobecks R, Pohlman B, Hamilton BK, Majhail NS, Hill BT. Mian A, et al. Among authors: khouri j. Leuk Lymphoma. 2021 Jun;62(6):1344-1352. doi: 10.1080/10428194.2020.1864349. Epub 2020 Dec 29. Leuk Lymphoma. 2021. PMID: 33375873

5

Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis.

Latif A, Kapoor V, Lateef N, Ahsan MJ, Usman RM, Malik SU, Ahmad N, Rosko N, Rudoni J, William P, Khouri J, Anwer F. Latif A, et al. Among authors: khouri j. Cardiovasc Hematol Disord Drug Targets. 2021;21(1):30-45. doi: 10.2174/1871529X21666210412113017. Cardiovasc Hematol Disord Drug Targets. 2021. PMID: 33845729

6

Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study.

Covut F, Ahmed R, Chawla S, Ricaurte F, Samaras CJ, Anwer F, Garcia AVM, Angelini DE, Mazzoni S, Faiman B, Valent J, Khouri J. Covut F, et al. Among authors: khouri j. Br J Haematol. 2021 Jun;193(6):1213-1219. doi: 10.1111/bjh.17505. Epub 2021 May 17. Br J Haematol. 2021. PMID: 33997961 Clinical Trial.

7

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy.

Chakraborty R, Rybicki L, Valent J, Garcia AVM, Faiman BM, Khouri J, Samaras CJ, Anwer F, Khorana AA. Chakraborty R, et al. Among authors: khouri j. Blood Cancer J. 2021 Jun 25;11(6):121. doi: 10.1038/s41408-021-00513-4. Blood Cancer J. 2021. PMID: 34172719 Free PMC article. No abstract available.

8

Dawn of a new era of antibody-drug conjugates and bispecific T-cell engagers for treatment of multiple myeloma: a systematic review of literature.

Khattak ZE, Hashmi H, Khan SI, Aamir S, Arif U, Khan AI, Darwin A, Singh AD, Khouri J, Anwer F. Khattak ZE, et al. Among authors: khouri j. Ann Hematol. 2021 Sep;100(9):2155-2172. doi: 10.1007/s00277-021-04599-5. Epub 2021 Jul 27. Ann Hematol. 2021. PMID: 34318356

9

Efficacy and Toxicity Profile of Carfilzomib-Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review.

Imtiaz H, Khan M, Ehsan H, Wahab A, Rafae A, Khan AY, Jamil A, Sana MK, Jamal A, Ali TJ, Ansar I, Khan MM, Khouri J, Anwer F. Imtiaz H, et al. Among authors: khouri j. Onco Targets Ther. 2021 Oct 1;14:4941-4960. doi: 10.2147/OTT.S317570. eCollection 2021. Onco Targets Ther. 2021. PMID: 34629878 Free PMC article. Review.

10

Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant.

Hegde PS, Rybicki L, Serafino S, Bernhard L, Corrigan D, Anwer F, Kalaycio M, Sobecks RM, Jagadeesh D, Hill BT, Dean RM, Khouri J, Winter AM, Pohlman B, Majhail NS, Hamilton BK. Hegde PS, et al. Among authors: khouri j. Bone Marrow Transplant. 2022 Jun;57(6):1031-1033. doi: 10.1038/s41409-022-01677-8. Epub 2022 Apr 15. Bone Marrow Transplant. 2022. PMID: 35428866 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters